Ixazomib: Mechanism, Dosage & Side Effects
Ixazomib is an oral cancer drug belonging to the class of proteasome inhibitors, used in the treatment of multiple myeloma.
Things worth knowing about "Ixazomib"
Ixazomib is an oral cancer drug belonging to the class of proteasome inhibitors, used in the treatment of multiple myeloma.
What is Ixazomib?
Ixazomib is a second-generation proteasome inhibitor and the first orally administered agent of this drug class. It is marketed under the brand name Ninlaro and is approved for the treatment of multiple myeloma – a malignant disease of plasma cells in the bone marrow. Ixazomib is administered as ixazomib citrate, which is rapidly converted to its active form in the body.
Indication
Ixazomib is approved in combination with lenalidomide and dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least one prior therapy. This three-drug combination has demonstrated efficacy in clinical trials in slowing disease progression and extending progression-free survival.
Mechanism of Action
Ixazomib selectively inhibits the 26S proteasome complex, a central cellular organelle responsible for degrading misfolded or damaged proteins. By blocking the proteasome, ubiquitinated proteins accumulate within cancer cells, leading to:
- Endoplasmic reticulum stress
- Activation of apoptotic signaling pathways (programmed cell death)
- Inhibition of tumor cell proliferation
Myeloma cells are particularly vulnerable to this type of stress because they produce large quantities of antibodies and therefore rely heavily on a functional proteasome.
Dosage and Administration
Ixazomib is administered orally as hard capsules. The recommended dose is 4 mg once weekly on days 1, 8, and 15 of a 28-day treatment cycle. The capsule should be taken at least one hour before or two hours after a meal. Dose adjustments may be necessary in patients with renal impairment or hepatic disease. Treatment is continued until disease progression or unacceptable toxicity occurs.
Side Effects
Like all cancer medicines, ixazomib can cause side effects. The most common include:
- Hematological effects: Thrombocytopenia (low platelet count), neutropenia, anemia
- Gastrointestinal complaints: Nausea, diarrhea, constipation, vomiting
- Peripheral neuropathy: Tingling, numbness, or pain in the hands and feet
- Skin reactions: Rash, dry skin
- Infections: Increased susceptibility to infections
- Edema: Swelling, particularly in the legs
Serious adverse events such as severe thrombocytopenia, hepatotoxicity, and thrombotic microangiopathy are less common but require close monitoring.
Treatment Context and Clinical Studies
The approval of ixazomib was largely based on the TOURMALINE-MM1 study, a phase III trial demonstrating that the triple combination of ixazomib, lenalidomide, and dexamethasone significantly prolonged median progression-free survival compared to placebo plus lenalidomide and dexamethasone. As the first all-oral proteasome inhibitor regimen, ixazomib offers patients a more convenient treatment option compared to intravenously or subcutaneously administered alternatives such as bortezomib or carfilzomib.
Interactions and Precautions
Ixazomib is metabolized primarily by CYP3A4. Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine) may reduce the efficacy of ixazomib and should be avoided. Strong CYP3A4 inhibitors may increase drug exposure. Regular blood count monitoring is recommended during therapy. Ixazomib is contraindicated during pregnancy and breastfeeding.
References
- Moreau P et al. - Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma. New England Journal of Medicine, 2016; 374(17):1621–1634.
- European Medicines Agency (EMA) - Ninlaro (Ixazomib): Summary of Product Characteristics. EMA, 2016. Available at: www.ema.europa.eu
- Rajkumar SV, Kumar S - Multiple Myeloma: Diagnosis and Treatment. Mayo Clinic Proceedings, 2016; 91(1):101–119.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryLactic acid
Lorlatinib
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Ixazomib